SOUTH SAN FRANCISCO, Calif., July 2, 2008 (PRIME NEWSWIRE) -- Hana Biosciences (Nasdaq:HNAB), a biopharmaceutical company focused on advancing cancer care, today announced that Steven R. Deitcher, M.D., President & Chief Executive Officer, will present a company update at the Collins Stewart Fourth Annual Growth Conference on Thursday, July 10, 2008 at 1:30 p.m. EDT at the Mandarin Oriental Hotel in New York, NY.
The presentation will be webcast live and archived on the company's website, www.hanabiosciences.com.
About Hana Biosciences, Inc.
Hana Biosciences, Inc. (Nasdaq:HNAB) is a South San Francisco, CA-based biopharmaceutical company focused on acquiring, developing, and commercializing innovative products to strengthen the foundation of cancer care. The company is committed to creating value by building a best-in-class team, accelerating the development of lead product candidates, expanding its pipeline by being an alliance partner of choice, and nurturing a unique company culture. Further information on Hana Biosciences can be found at www.hanabiosciences.com.
The Hana Biosciences, Inc. logo is available at http://www.primenewswire.com/newsroom/prs/?pkgid=3290